Decrease of Let-7f in Low-Dose Metronomic Paclitaxel Chemotherapy Contributed to Upregulation of Thrombospondin-1 in Breast Cancer

Low-dose metronomic (LDM) paclitaxel therapy displayed a stronger anti-angiogenic activity on breast tumors with fewer side effects. Upregulation of anti-angiogenic factor Thrombospondin-1 (TSP-1) accords for therapeutic potency of LDM paclitaxel, but its molecular mechanism has not been elucidated...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Wei-Yang, Liang, Xiao-Shuan, Liu, Yang, Wang, Chun-Yang, Pang, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278254/
https://www.ncbi.nlm.nih.gov/pubmed/25552929
http://dx.doi.org/10.7150/ijbs.9969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278254/
https://www.ncbi.nlm.nih.gov/pubmed/25552929
http://dx.doi.org/10.7150/ijbs.9969

Ejemplares similares